These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36420075)

  • 1. Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA.
    Wang J; Song Z; Ren L; Zhang B; Zhang Y; Yang X; Liu T; Gu Y; Feng C
    Oncol Lett; 2022 Dec; 24(6):445. PubMed ID: 36420075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
    Wu X; Chen H; You C; Peng Z
    Hereditas; 2023 May; 160(1):21. PubMed ID: 37170390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():849592. PubMed ID: 35444654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma.
    Liu Y; Zhang H; Zhao S; Zhang Y
    Clin Transl Oncol; 2024 Dec; 26(12):2966-2978. PubMed ID: 38773060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.
    Ding JT; Yu XT; He JH; Chen DZ; Guo F
    Front Genet; 2022; 13():912003. PubMed ID: 35783266
    [No Abstract]   [Full Text] [Related]  

  • 7. Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma.
    Wang Z; Zheng W; Chen Z; Wu S; Chang H; Cai M; Cai H
    Front Oncol; 2022; 12():1055376. PubMed ID: 36531056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers.
    Li Z; Pu Z; Yang Z; Zhu Y; Deng Y; Li N; Peng F
    Front Oncol; 2022; 12():971618. PubMed ID: 36419876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA small nucleolar RNA host gene 7 is upregulated and promotes cell proliferation in thyroid cancer.
    Chen L; Zhu J; Zhang LJ
    Oncol Lett; 2019 Nov; 18(5):4726-4734. PubMed ID: 31611982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis.
    Zheng X; Chen L; Liu W; Zhao S; Yan Y; Zhao J; Tian W; Wang Y
    Hereditas; 2023 Mar; 160(1):13. PubMed ID: 36964635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma.
    Li C; Tang Y; Li Q; Liu H; Ma X; He L; Shi H
    Front Immunol; 2023; 14():1131870. PubMed ID: 36969231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
    Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
    Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern, immune signature, and prognostic value of RBM10 in human cancers.
    Sun X; Jia D; Yu Y
    Histol Histopathol; 2024 Jul; ():18790. PubMed ID: 39056107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive pan-cancer analysis revealing
    Li X; Wang Y; Li X; Kong L; Díez JJ; Wang H; Zhang D
    Gland Surg; 2024 Jun; 13(6):999-1015. PubMed ID: 39015705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.